Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00074100 · ClinicalTrials.gov registry record · Phase 2
Amonafide in Treating Women With Metastatic Breast Cancer That Has Progressed After Previous Chemotherapy
A Phase 2 study, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00074100: Completed Phase 2 study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00074100 is a Phase 2 study that has completed, run by Memorial Sloan Kettering Cancer Center. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00074100, a Phase 2 study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
RATIONALE: Drugs used in chemotherapy, such as amonafide, work in different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of amonafide in treating women who have metastatic breast cancer that has progressed after previous chemotherapy.
Interventions
- DRUG amonafide dihydrochloride
Trial Details
| Field | Value |
|---|---|
| Start Date | 2003-08 |
| Est. Completion | 2004-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00074100
The ClinicalTrials.gov registry entry for NCT00074100 describes a study currently listed as completed, categorized as Phase 2. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which amonafide dihydrochloride is the first listed.
NCT00074100 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00074100 about?
NCT00074100 is a clinical study titled "Amonafide in Treating Women With Metastatic Breast Cancer That Has Progressed After Previous Chemotherapy". RATIONALE: Drugs used in chemotherapy, such as amonafide, work in different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of amonafide in treating women who have metastatic breast cancer that has progressed after previous chem...
What is the current status of trial NCT00074100?
This trial is currently completed. It is a Phase 2 study. The study started on 2003-08. Estimated completion is 2004-09.
What interventions are being tested in trial NCT00074100?
The interventions under investigation include: amonafide dihydrochloride (DRUG).
Who is sponsoring clinical trial NCT00074100?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.